Acadia Pharmaceuticals

ACAD

NASDAQHealth Care

Income Statement

Total Revenue$957.8M

Gross Profit$875.96M

Operating Income$230.79M

EBITDA$273.96M

EBIT$258.08M

Pre-tax Income$115.11M

Net Income$226.45M

Cash Equivalent$221.42M

Total Debt$44.71M

Book Value$572.68M

Book Value Per Share3.46

Return on Equity (ROE)+30.83%

Return on Assets (ROA)+19.02%

Return on Invested Capital (ROI)+30.83%

Net Profit Margin+23.60%

Current Ratio2.37

Quick Ratio2.18

Long-Term Debt / Equity0.01